Papers: 10.1093/jtm/taab026

https://doi.org/10.1093/jtm/taab026

What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective

Cited by: 10
Author(s): HU Ying-lian, Simiao Chen
Published: over 5 years ago

Software Mentions 1